235 related articles for article (PubMed ID: 8279030)
1. Simultaneous allografting and autografting of skin for ulcers in a bone marrow transplant patient.
Kamei Y; Torii S; Hasegawa M; Toriyama K; Kodera Y
Transplantation; 1993 Dec; 56(6):1530-1. PubMed ID: 8279030
[No Abstract] [Full Text] [Related]
2. Allogeneic skin grafting for extensive skin chronic graft-versus-host disease.
Kondo S; Tamura K; Makino S; Takamatsu Y
Int J Hematol; 1994 Aug; 60(2):151-5. PubMed ID: 7948965
[TBL] [Abstract][Full Text] [Related]
3. [Allogeneic skin transplantation in chronic graft-versus-host disease following bone marrow transplantation].
Baumeister RG; Riel KA; Kolb HJ
Chirurg; 1990 Jun; 61(6):438-40. PubMed ID: 2364784
[TBL] [Abstract][Full Text] [Related]
4. Chronic Ulcer by Cutaneous GvHD After Bone Marrow Transplantation Treated With Skin Allograft From HLA-Identical Donor: Case Report and Literature Review.
Amendola F; Gazzola R; Lombardo M; Caminiti R; Dagna L; Baruffaldi-Preis FW
Int J Low Extrem Wounds; 2016 Jun; 15(2):139-41. PubMed ID: 27009789
[TBL] [Abstract][Full Text] [Related]
5. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
[TBL] [Abstract][Full Text] [Related]
6. Role of autologous bone marrow transplantation for patients with acute and chronic leukemias.
Geller RB
Hematol Oncol Clin North Am; 1993 Jun; 7(3):547-75. PubMed ID: 8344882
[TBL] [Abstract][Full Text] [Related]
7. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
[TBL] [Abstract][Full Text] [Related]
8. Acquired ichthyosis in bone marrow transplant recipients.
Spelman LJ; Strutton GM; Robertson IM; Weedon D
J Am Acad Dermatol; 1996 Jul; 35(1):17-20. PubMed ID: 8682957
[TBL] [Abstract][Full Text] [Related]
9. The influence of the graft monocytes in the outcome of allogeneic bone marrow transplantation.
Aranha FJ; Vigorito AC; De Sousa CA; Oliveira GB; Zulli R; Lorand-Metze I
Haematologica; 2002 Feb; 87(2):219-20. PubMed ID: 11836174
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous infection with Mycobacterium fortuitum after allogeneic bone marrow transplantation.
Okano A; Shimazaki C; Ochiai N; Hatsuse M; Takahashi R; Ashihara E; Inaba T; Fujita N; Noda Y; Nakagawa M
Bone Marrow Transplant; 2001 Oct; 28(7):709-11. PubMed ID: 11704796
[TBL] [Abstract][Full Text] [Related]
11. Contrast media triggering cutaneous graft-versus-host disease.
Vavricka SR; Halter J; Furrer K; Wolfensberger U; Schanz U
Bone Marrow Transplant; 2002 Jun; 29(11):899-901. PubMed ID: 12080354
[TBL] [Abstract][Full Text] [Related]
12. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
[TBL] [Abstract][Full Text] [Related]
13. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
[TBL] [Abstract][Full Text] [Related]
14. Organ tolerance following cadaveric liver transplantation for chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Urban CH; Deutschmann A; Kerbl R; Lackner H; Schwinger W; Königsrainer A; Margreiter R
Bone Marrow Transplant; 2002 Oct; 30(8):535-7. PubMed ID: 12379895
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of a refractory skin ulcer in chronic cutaneous GvHD after allogeneic HSCT with split-thickness skin allografting from the stem cell donor.
Ammer J; Prantl L; Holler B; Landfried K; Wolff D; Karrer S; Andreesen R; Holler E
Bone Marrow Transplant; 2012 Oct; 47(10):1368-9. PubMed ID: 22343673
[No Abstract] [Full Text] [Related]
16. Clinical and hematologic response of chronic lymphocytic and prolymphocytic leukemia persisting after allogeneic bone marrow transplantation with the onset of acute graft-versus-host disease: possible role of graft-versus-leukemia.
Mehta J; Powles R; Singhal S; Iveson T; Treleaven J; Catovsky D
Bone Marrow Transplant; 1996 Mar; 17(3):371-5. PubMed ID: 8704689
[TBL] [Abstract][Full Text] [Related]
17. Soft tissue sarcoma in the setting of chronic cutaneous graft versus host disease after allogenic bone marrow transplantation.
Bylund KC; Giampoli E; Singh D; Doerr T; Sahasrabudhe D; Liesveld J; Constine LS
Cancer Invest; 2008 Jul; 26(6):638-41. PubMed ID: 18584356
[TBL] [Abstract][Full Text] [Related]
18. Is there an upper age limit for bone marrow transplantation?
Popplewell LL; Forman SJ
Bone Marrow Transplant; 2002 Feb; 29(4):277-84. PubMed ID: 11896423
[TBL] [Abstract][Full Text] [Related]
19. Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.
Atkinson K; Downs K
Bone Marrow Transplant; 1995 Dec; 16(6):755-8. PubMed ID: 8750265
[TBL] [Abstract][Full Text] [Related]
20. Immunologic tolerance to skin allograft after graft-versus-host disease.
Elias BG; Meunier DI; Squifflet JP; Marot L; Weynand B; VanWijck RR; Bayet B
Plast Reconstr Surg; 2007 Mar; 119(3):40e-44e. PubMed ID: 17312474
[No Abstract] [Full Text] [Related]
[Next] [New Search]